400 related articles for article (PubMed ID: 29064714)
1. Gated Mesoporous Silica Nanocarriers for a "Two-Step" Targeted System to Colonic Tissue.
González-Alvarez M; Coll C; Gonzalez-Alvarez I; Giménez C; Aznar E; Martínez-Bisbal MC; Lozoya-Agulló I; Bermejo M; Martínez-Máñez R; Sancenón F
Mol Pharm; 2017 Dec; 14(12):4442-4453. PubMed ID: 29064714
[TBL] [Abstract][Full Text] [Related]
2. Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells.
Giménez C; de la Torre C; Gorbe M; Aznar E; Sancenón F; Murguía JR; Martínez-Máñez R; Marcos MD; Amorós P
Langmuir; 2015 Mar; 31(12):3753-62. PubMed ID: 25742160
[TBL] [Abstract][Full Text] [Related]
3. Smart gated magnetic silica mesoporous particles for targeted colon drug delivery: New approaches for inflammatory bowel diseases treatment.
Teruel AH; Pérez-Esteve É; González-Álvarez I; González-Álvarez M; Costero AM; Ferri D; Parra M; Gaviña P; Merino V; Martínez-Mañez R; Sancenón F
J Control Release; 2018 Jul; 281():58-69. PubMed ID: 29753956
[TBL] [Abstract][Full Text] [Related]
4. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N
Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin-B induced controlled release from peptide-capped mesoporous silica nanoparticles.
de la Torre C; Mondragón L; Coll C; Sancenón F; Marcos MD; Martínez-Máñez R; Amorós P; Pérez-Payá E; Orzáez M
Chemistry; 2014 Nov; 20(47):15309-14. PubMed ID: 25303093
[TBL] [Abstract][Full Text] [Related]
6. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.
Jiao J; Liu C; Li X; Liu J; Di D; Zhang Y; Zhao Q; Wang S
J Colloid Interface Sci; 2016 Dec; 483():343-352. PubMed ID: 27569517
[TBL] [Abstract][Full Text] [Related]
9. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
[TBL] [Abstract][Full Text] [Related]
10. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
11. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
[TBL] [Abstract][Full Text] [Related]
12. MUC1 aptamer-capped mesoporous silica nanoparticles for controlled drug delivery and radio-imaging applications.
Pascual L; Cerqueira-Coutinho C; García-Fernández A; de Luis B; Bernardes ES; Albernaz MS; Missailidis S; Martínez-Máñez R; Santos-Oliveira R; Orzaez M; Sancenón F
Nanomedicine; 2017 Nov; 13(8):2495-2505. PubMed ID: 28842375
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides".
Bernardos A; Mondragon L; Aznar E; Marcos MD; Martinez-Mañez R; Sancenon F; Soto J; Barat JM; Perez-Paya E; Guillem C; Amoros P
ACS Nano; 2010 Nov; 4(11):6353-68. PubMed ID: 20958020
[TBL] [Abstract][Full Text] [Related]
14. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
15. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
Zhang K; Zhou D; Wang Z; Zhang Y; He P
Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
[TBL] [Abstract][Full Text] [Related]
16. Controlled drug release with surface-capped mesoporous silica nanoparticles and its label-free in situ Raman monitoring.
Lee S; Kwon JA; Park KH; Jin CM; Joo JB; Choi I
Eur J Pharm Biopharm; 2018 Oct; 131():232-239. PubMed ID: 30165104
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica nanorods for improved oral drug absorption.
Zheng N; Li J; Xu C; Xu L; Li S; Xu L
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1132-1140. PubMed ID: 28783976
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
19. Functional Magnetic Mesoporous Silica Microparticles Capped with an Azo-Derivative: A Promising Colon Drug Delivery Device.
Teruel AH; Coll C; Costero AM; Ferri D; Parra M; Gaviña P; González-Álvarez M; Merino V; Marcos MD; Martínez-Máñez R; Sancenón F
Molecules; 2018 Feb; 23(2):. PubMed ID: 29439396
[TBL] [Abstract][Full Text] [Related]
20. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
